发明名称 |
Compuestos farmacéuticamente activos como inhibidores AXL |
摘要 |
<p>The present invention relates to 1-nitrogen-heterocyclic-2-carboxamides of general formula (I):
and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the treatment and/or prevention of Axl receptor tyrosine kinase subfamily induced disorders, including cancer and primary tumor metastases, and pharmaceutical compositions containing at least one of said 1-nitrogen-heterocyclic-2-carboxamide derivatives and/or pharmaceutically acceptable salts thereof.</p> |
申请公布号 |
ES2530492(T3) |
申请公布日期 |
2015.03.03 |
申请号 |
ES20110754617T |
申请日期 |
2011.08.26 |
申请人 |
LEAD DISCOVERY CENTER GMBH;MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. |
发明人 |
SCHULTZ-FADEMRECHT, CARSTEN;KLEBL, BERT;CHOIDAS, AXEL;KOCH, UWE;EICKHOFF, JAN;WOLF, ALEXANDER;ULLRICH, AXEL |
分类号 |
C07D401/12;A61K31/4709;A61P35/00;C07D215/233;C07D401/14;C07D413/12;C07D413/14;C07D417/12;C07D417/14 |
主分类号 |
C07D401/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|